Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDUA | P35475 | 1/20 | 0.36 |
| ▸ | GUSB | P08236 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.31 |
| ▸ | PRKCA | P17252 | 3/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15210146 | 1.00 | IDUA (0.36) | IDUAGUSBLMNATSHRKDM4E | |
| Lactic Acid SCHEMBL7156907 | 0.94 | TP53 (0.34) | IDUAGUSBTSHRCA1CA9 | |
| SCHEMBL9846802 | 0.87 | IDUA (0.39) | IDUAGUSBLMNATSHRCA1 | |
| SCHEMBL2048950 | 0.75 | PRKCA (0.39) | LMNAL3MBTL1CA1CA9PRKCA | |
| SCHEMBL1686987 | 0.74 | SLC6A3 (0.46) | LMNAKDM4EPOLBL3MBTL1CA1 | |
| SCHEMBL9114040 | 0.73 | CA1 (0.40) | TSHRCA1CA9PRKCA | |
| SCHEMBL23530392 | 0.71 | PRKCA (0.32) | PRKCA | |
| SCHEMBL15210168 | 0.71 | MMP3 (0.36) | TSHRKDM4E | |
| SCHEMBL23530390 | 0.71 | PRKCA (0.32) | PRKCA | |
| SCHEMBL29825911 | 0.71 | PRKCA (0.32) | PRKCA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8916615-B2 | PH-sensitive polymer hydrogel with dual ionic transition and use thereof | Research & Business Foundation Sungkyunkwan University (KR) | 2014-12-23 | — | — | US | claimed |
| US-20130225696-A1 | pH-SENSITIVE POLYMER HYDROGEL WITH DUAL IONIC TRANSITION AND USE THEREOF | Research & Business Foundation Sungkyunkwan University (KR) | 2013-08-29 | — | — | US | claimed |
| JP-8182751-A | — | — | None | — | — | JP | disclosed |
| WO-2024059259-A9 | COMPOSITION AND METHOD FOR A ROOT CANAL SEALER | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2024-05-10 | — | — | WO | disclosed |
| US-11944724-B2 | In situ forming hemostatic foam implants | ARSENAL MEDICAL, INC. (US) | 2024-04-02 | — | — | US | disclosed |
| WO-2024059259-A1 | COMPOSITION AND METHOD FOR A ROOT CANAL SEALER | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2024-03-21 | — | — | WO | disclosed |
| US-20230414840-A1 | IN SITU FORMING HEMOSTATIC FOAM IMPLANTS | ARSENAL MEDICAL, INC. | 2023-12-28 | — | — | US | disclosed |
| US-11786642-B2 | In situ forming hemostatic form implants | ARSENAL MEDICAL, INC. (US) | 2023-10-17 | — | — | US | disclosed |
| US-20230241360-A1 | TEMPORARY OCCLUSION BALLOON DEVICES AND METHODS FOR PREVENTING BLOOD FLOW THROUGH A VASCULAR PERFORATION | SPECTRANETICS LLC (CO) | 2023-08-03 | — | — | US | disclosed |
| US-20220226199-A1 | COMPOSITION AND METHOD FOR A ROOT CANAL FILLING | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY | 2022-07-21 | — | — | US | disclosed |
| US-20220105248-A1 | IN SITU FORMING HEMOSTATIC FOAM IMPLANTS | ARSENAL MEDICAL, INC. | 2022-04-07 | — | — | US | disclosed |
| US-20080082177-A1 | Device for tissue reinforcement having microporous and macroporous structures | ETHICON, INC. | 2008-04-03 | — | — | US | disclosed |
| EP-1741393-A1 | Foam matrix encapsulated embolization device | Cordis Corporation (US) | 2007-01-10 | — | — | EP | disclosed |
| US-20070001346-A1 | Active embolization device | CODMAN & SHURTLEFF, INC. | 2007-01-04 | — | — | US | disclosed |
| EP-1738695-A1 | Method of making a coated embolization device | Cordis Development Corporation (US) | 2007-01-03 | — | — | EP | disclosed |
| US-20060058834-A1 | Foam matrix embolization device | CORDIS CORPORATION | 2006-03-16 | — | — | US | disclosed |
| US-6861087-B2 | Preparation method of biodegradable porous polymer scaffolds having an improved cell compatibility for tissue engineering | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2005-03-01 | — | — | US | disclosed |
| US-20050036946-A1 | Radio-opaque compounds, compositions containing same and methods of their synthesis and use | PATHAK HOLDINGS, LLC | 2005-02-17 | — | — | US | disclosed |
| US-20040043135-A1 | Preparation method of biodegradable porous polymer scaffolds having an improved cell compatibility for tissue engineering | SOLCO BIOMEDICAL CO., LTD. (KR) | 2004-03-04 | — | — | US | disclosed |
| JP-H08182751-A | SUTURE FOR SURGERY AND ITS PREPARATION | GUNZE LTD | 1996-07-16 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050036946-A1 | Radio-opaque compounds, compositions containing same and methods of their synthesis and use | PLOD3, IK, SON | IDUA 108/4885GUSB 1537/4885LMNA 719/4885 |
| US-20220226199-A1 | COMPOSITION AND METHOD FOR A ROOT CANAL FILLING | PEF1, NUP205, POP1 | IDUA 2581/4885GUSB 458/4885LMNA 538/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.